Increased Risk of Malignant Melanoma in Patients with Systemic Mastocytosis?

By Hägglund Hans   Sander Birgitta   Gülen Theo   Lindelöf Bernt   Nilsson Gunnar  

Acta Dermato-Venereologica, Vol. 94, Iss. 5, 2014-09 ,pp. : 583-584

Medical Journals Limited

Access to resources Recommend Favorite

Drug therapy for advanced melanoma: a nursing perspective

By Duncan Rachel  

Dermatological Nursing, Vol. 14, Iss. 3, 2015-09 ,pp. : 24-28

British Dermatological Nursing Group

Access to resources Recommend Favorite

Recent advances in laser dermatology

By Butani Anjali   Dudelzak Jacob   Goldberg David  

Journal of Cosmetic and Laser Therapy, Vol. 11, Iss. 1, 2009-03 ,pp. : 2-10

Informa Healthcare

Access to resources Recommend Favorite

Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2

By Ma Chelsea   Armstrong April W  

Journal of Dermatological Treatment, Vol. 25, Iss. 5, 2014-10 ,pp. : 401-408

Informa Healthcare

Access to resources Recommend Favorite

Systemic Combination Treatment for Psoriasis: A Review

By Jensen Peter   Skov Lone   Zachariae Claus  

Acta Dermato-Venereologica, Vol. 90, Iss. 4, 2010-06 ,pp. : 341-349

Medical Journals Limited

Access to resources Recommend Favorite